EDP-1815

N/A

Report date: 2024/01/23 15:26:41

Base Information

Drug NameEDP-1815
Drug Alias NameEDP-1815
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPlaque psoriasisCoronavirus Disease 2019 (COVID-19)Psoriasis +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[10
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEvelo Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEvelo Biosciences Inc
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisCoronavirus Disease 2019 (COVID-19)Psoriasis +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A